Contact
As a senior associate, Roxane has developed a solid knowledge in data protection, advising on both contentious and non-contentious matters. Roxane's practice also covers commercial and contractual law as well as life sciences. Roxane thus brings a holistic approach to the client's projects and understands the legal needs of clients from various industries.
Roxane notably assists clients from various sectors on all aspects of data protection and carries out comprehensive data protection compliance assessments. She assists clients from the life sciences sector in matter of health data protection issues and other health regulatory questions. She also helps clients in the drafting and negotiating of complex contracts.
Roxane has also in-house counsel experience since she was seconded during several months to a U.S. group and ensured day-to-day legal needs of its French subsidiaries.
Prior to joining August Debouzy, Roxane worked at the Paris offices of two well-known global law firms.
Paris, 2013
French | English
AD Article
Artificial intelligence (“AI”) and megadata in the medical research and practice area: the key points to take away from the conference dated February 10th, 2023 organized by the French Supreme Administrative Court (“Conseil d’Etat”) and the French data protection authority (“CNIL”)
Health is undeniably one of the fields where AI has already demonstrated the real interest of its use for human support. AI can, for example, help diagnose
AD Article
Intelligence artificielle (« IA ») et mégadonnées dans le domaine de la recherche et de la pratique médicales : les éléments clés à retenir du colloque organisé par le Conseil d’Etat, la CNIL et l’Alliance IHU France
La santé est indéniablement l’un des domaines où l’IA a déjà démontré le réel intérêt de son utilisation pour l’accompagnement de l’humain. L’IA peut par exemple être une aide au diagnostic en détectant des maladies sur de l’imagerie médicale grâce à une analyse plus fine que l’œil humain. Des montres connectées basées sur l’IA sont susceptibles de signaler une insuffisance cardiaque alors que, jusque-là, ce type de pathologie supposait, pour leur détection, un coûteux échocardiogramme, scanner ou IRM. L’IA, qui reste une discipline assez jeune, offre encore bien des promesses de futures révolutions que ce soit en termes de qualité et d’accessibilité du soin ou de mise au point de traitements.
AD Deal
August Debouzy advised three investment funds on their acquisition of an equity interest in DNA Script
August Debouzy advised Coatue Management, Catalio Capital Management, and Fidelity Management and Research on their acquisition of an equity interest in DNA Script, a pioneer in DNA printing, as part of a €142 million Series C financing round involving seven new investors.
AD Deal
August Debouzy advises Spectral TMS on its fundraising campaign
August Debouzy advised Spectral TMS, a leading French startup in the field of autonomous augmented reality for the industrial sector, on its €2 million seed financing round which marks the entry into its capital of Elaia, along with Spectral TMS's historical investors.
AD Article
"Cookie walls" - the French Conseil d'Etat invalidates part of the CNIL's guidelines on cookies and other tracking devices
France’s Highest Administrative Court (the “Conseil d'Etat”) has just issued its decision on the guidelines on cookies and other tracking devices ("cookies") adopted by the CNIL on July 4, 2019 (the "guidelines"), following an action for annulment brought by various trade unions and professional associations in the advertising, e-commerce and media sectors.
AD Article
Recommendations provided by the CNIL’s President, who was heard by the Law Commission on April 8, 2020, regarding the tracking of individuals in connection with the health crisis.
On Wednesday, April 8, 2020, the CNIL’s President appeared and was heard before the Law Commission of the French National Assembly about the French Government's work on the use of location-based tracking technologies.
AD Article
Data hunting, including location data, in a health crisis situation: addressing the issue of the right of individuals to privacy and the protection of their personal data
The coronavirus crisis is the occasion to note the emergence of certain initiatives that are either legitimate and controlled or abusive and intrusive, and that come from both private entities and state authorities, involving the use, sometimes massive, of data, including personal data.
AD Article
Update on the possibility for French private entities whose business is maintained to collect personal health data as part of the fight against coronavirus – March 16, 2020
As a reminder, a data controller may only process personal data based on one of the lawful grounds provided for by Article 6 of the General Data Protection Regulation (“GDPR”) and, in case of sensitive data, on one of the exceptions to the prohibition on processing such data under Article 9 of the GDPR. The importance of respecting these principles, even in times of crisis, is reminded by the European Data Protection Board (EDPB) in its press release published on March 16, 2020.
AD Article
Does the war against coronavirus justify all types of processing of personal data, especially in the workplace?
Even in a crisis situation, any data controller should consider and ensure the lawfulness of the processing of personal data that it wishes to carry out. The data controller may only process personal data based on one of the lawful grounds provided for by the General Data Protection Regulation ("GDPR" - Article 6) and, in case of sensitive data (such as health data), if it can rely on one of the exceptions to the prohibition on processing sensitive data provided for by the GDPR (Article 9).
More
Publications